Current Evidence on the Relationship Between Two Polymorphisms in the NBS1 Gene and Breast Cancer Risk: a Meta-analysis |
Zhang, Zhi-Hua
(Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University)
Yang, Lin-Sheng (Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University) Huang, Fen (Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University) Hao, Jia-Hu (Department of Maternal and Child Health, School of Public Health, Anhui Medical University) Su, Pu-Yu (Department of Maternal and Child Health, School of Public Health, Anhui Medical University) Sun, Ye-Huan (Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University) |
1 | Bogdanova N, Feshchenko S, Schurmann P, et al (2008a). Nijmegen Breakage Syndrome mutations and risk of breast cancer. Int J Cancer, 122, 802-6. DOI |
2 | Bogdanova N, Schurmann P, Waltes R, et al (2008b). NBS1 variant I171V and breast cancer risk. Breast Cancer Res Treat, 112, 75-9. DOI |
3 | Buslov KG, Iyevleva AG, Chekmariova EV, et al (2005). NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia. Int J Cancer, 114, 585-9. DOI |
4 | Carlomagno F, Chang-Claude J, Dunning AM, et al (1999). Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer. Genes Chromosomes Cancer, 25, 393-5. DOI |
5 | DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. DOI |
6 | Desjardins S, Beauparlant JC, Labrie Y, et al (2009). Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer. BMC Cancer, 9, 181. DOI |
7 | Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. DOI |
8 | Gorski B, Cybulski C, Huzarski T, et al (2005). Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat, 92, 19-24. DOI |
9 | Gorski B, Debniak T, Masojc B, et al (2003). Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int J Cancer, 106, 379-81. DOI |
10 | Kanka C, Brozek I, Skalska B, et al (2007). Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland. Anticancer Res, 27, 3015-8. |
11 | Lau J, Ioannidis JP, and Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6. DOI ScienceOn |
12 | Mantel N, and Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
13 | Mosor M, Ziolkowska I, Pernak-Schwarz M, et al (2006). Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia. Leukemia, 20, 1454-6. DOI |
14 | Nowak J, Mosor M, Ziolkowska I, et al (2008). Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours. Eur J Cancer, 44, 627-30. DOI |
15 | Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. DOI ScienceOn |
16 | Pharoah PD, Dunning AM, Ponder BA, et al (2004). Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer, 4, 850-60. DOI |
17 | Roznowski K, Januszkiewicz-Lewandowska D, Mosor M, et al (2008). I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer. Breast Cancer Res Treat, 110, 343-8. DOI |
18 | Varon R, Seemanova E, Chrzanowska K, et al (2000). Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. Eur J Hum Genet, 8, 900-902. DOI |
19 | Steffen J, Nowakowska D, Niwinska A, et al (2006). Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. Int J Cancer, 119, 472-5. DOI |
20 | Steffen J, Varon R, Mosor M, et al (2004). Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int J Cancer, 111, 67-71. DOI |
21 | Ziolkowska I, Mosor M, Wierzbicka M, et al (2007). Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Cancer Sci, 98, 1701-5. DOI |
![]() |